References
- Bedell, S. L., Goldstein, L. S., Goldstein, A. R., Goldstein, A. T. (2020). Cervical cancer screening: Past, present, and future. Sex Med., 8 (1), 28–37.10.1016/j.sxmr.2019.09.00531791846
- Bedoya, A. M., Jaramillo. R., Baena, A., Castano, J., Olaya, N., Zea, A. H., Herrero, R., Sanchez, G. I. (2013). Location and density of immune cells in precursor lesions and cervical cancer. Cancer Microenviron., 6 (1), 69–77.10.1007/s12307-012-0097-8360121522290207
- Brenton, J. D., Ellenson, L. H., Gilks, C. B., Herrington, C. S. (2019). WHO Classification of Tumours. 5th edition. Vol. 4. WHO. Lyon, 632 pp.
- Brito, M. J., Sequeira, P., Silva, I., Quintas, A., Martins, C., Félix, A. (2021). CD4 + and CD8 + cell populations in HIV-positive women with cervical squamous intra-epithelial lesions and squamous cell carcinoma. Int. J. Infect. Dis., 103, 370–377.10.1016/j.ijid.2020.10.08333157285
- Bonin, C. M., Padovani, C. T. J., da Costa, I. P, Ávila, L. S., Ferreira, A. M. T., Fernandes, C. E. S., Dos Santos, A. R., Tozetti, I. A. (2018). Detection of regulatory T cell phenotypic markers and cytokines in patients with human papillomavirus infection, J. Med. Virol., 91, 2, 317–325.10.1002/jmv.25312
- Das, D., Sarkar, B., Mukhopadhyay, S., Banerjee, C., Biswas, S. M. (2018). An altered ratio of CD4+ and CD8+ T lymphocytes in cervical cancer tissues and peripheral blood — a prognostic clue? Asian Pac. J. Cancer Prev., 19 (2), 471.
- Gholami, D. M., Kardar, G. A., Saeedi, Y., Heydari, S., Garssen, J., Falak, R. (2017). Exhaustion of T lymphocytes in the tumor microenvironment: Significance and effective mechanisms. Cell Immunol., 322,1–14.10.1016/j.cellimm.2017.10.00229079339
- Gurrola-Diaz, C. M., Suarez-Rincon, A. E., Vazquez-Camacho, G., Buonocunto-Vazquez, G., Rosales-Quintana, S., Wentzensen, N., von Knebel Doeberitz, M. (2008). P16INK4a immunohistochemistry improves the reproducibility of the histological diagnosis of cervical intraepithelial neoplasia in cone biopsies. Gynecol. Oncol., 111, 120–124.10.1016/j.ygyno.2008.06.03218692882
- Guzm an-Olea, E., Bermu dez-Morales, V. H., Peralta-Zaragoza, O., Torres-Poveda, K., Madrid-Marina, V. (2012). Molecular mechanism and potential targets for blocking HPV-induced lesion development. J. Oncol., 20, 278312.10.1155/2012/278312
- Kojima, S., Kawana, K., Tomio, K., Yamashita, A., Taguchi, A., Miura, S., Adachi, K., Nagamatsu, T., Nagasaka, K., Matsumoto, Y., et al. (2013). The prevalence of cervical regulatory T cells in HPV-related cervical intraepithelial neoplasia (CIN) correlates inversely with spontaneous regression of CIN. Amer. J. Reprod. Immunol., 69 (2), 134–141.10.1111/aji.1203023057776
- Loddenkemper, C., Hoffmann, C., Stanke, J., Nagorsen, D., Baron, U., Olek, S., Huehn, J., Ritz, J. P., Stein, H., Kaufmann, A. M., Schneider, A., Cichon, C. (2009). Regulatory (FOXP3+) T cells as target for immune therapy of cervical intraepithelial neoplasia and cervical cancer. Cancer Sci., 100 (6), 1112–1117.10.1111/j.1349-7006.2009.01153.x19514119
- Litwin, T. R., Irvin, S. R., Chornock, R. L., Sahasrabuddhe, V. V., Stanley, M., Wentzensen, N. (2021). Infiltrating T-cell markers in cervical carcinogenesis: A systematic review and meta-analysis. Brit. J. Cancer., 124 (4), 831–841.10.1038/s41416-020-01184-x788459233257839
- Martin, C. M., O’Leary, J. J., Phil, D. (2011). Histology of cervical intraepithelial neoplasia and the role of biomarkers. Best Pract. Res. Clin. Obstet. Gynaecol., 25, 605–615.10.1016/j.bpobgyn.2011.04.005
- Maskey, N., Thapa, N., Maharjan, M., Shrestha, G., Maharjan, N., Cai, H., Liu, S. (2019). Infiltrating CD4 and CD8 lymphocytes in HPV infected uterine cervical milieu. Cancer Manag Res., 14 (11), 7647-–7655.10.2147/CMAR.S217264669860431616181
- Molina, M. A., Carosi Diatricch, L., Castany Quintana, M., Melchers, W. J., Andralojc, K. M. (2020). Cervical cancer risk profiling: Molecular biomarkers predicting the outcome of hrHPV infection. Expert Rev. Mol. Diagn., 20 (11), 1099–1120.10.1080/14737159.2020.183547233044104
- Monnier-Benoit, S., Mauny, F., Riethmuller, D., Guerrini, J. S., Cãpîlna, M., Félix, S., Seillès, E., Mougin, C., Prétet, J. L. (2006). Immunohisto-chemical analysis of CD4+ and CD8+ T-cell subsets in high risk human papillomavirus-associated pre-malignant and malignant lesions of the uterine cervix. Gynecol Oncol., 102 (1), 22–31.10.1016/j.ygyno.2005.11.03916427684
- Nguyen, H. H., Broker, T. R., Chow, L. T., Alvarez, R. D., Vu, H. L., Andrasi, J., Brewer, L. R., Jin, G., Mestecky, J. (2005). Immune responses to human papillomavirus in genital tract of women with cervical cancer. Gynecol Oncol., 96 (2), 452–461.10.1016/j.ygyno.2004.10.01915661235
- Ostroumov, D., Fekete-Drimusz, N., Saborowski, M., Kühnel, F., Woller, N. (2018). CD4 and CD8 T lymphocyte interplay in controlling tumor growth. Cell Mol. Life Sci., 75, 689.10.1007/s00018-017-2686-7576982829032503
- Øvestad, I. T., Gudlaugsson, E., Skaland, I., Malpica, A., Kruse, A. J., Janssen, E. A, Baak, J. P. (2010). Local immune response in the micro-environment of CIN2-3 with and without spontaneous regression. Mod. Pathol., 23 (9),1231–1240.10.1038/modpathol.2010.10920512116
- Ozaki, S., Zen, Y., Inoue, M. (2011). Biomarker expression in cervical intraepithelial neoplasia: Potential progression predictive factors for low-grade lesions. Hum. Pathol., 42,1007–1012.10.1016/j.humpath.2010.10.02121315414
- Shang, B., Liu, Y., Jiang, S. J., Liu, Y (2015). Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis. Sci Rep., 5,15179.10.1038/srep15179460447226462617
- Shibata, T., Lieblong, B. J., Sasagawa, T., Nakagawa, M. (2019). The promise of combining cancer vaccine and checkpoint blockade for treating HPV-related cancer. Cancer Treatment Rev., 10, 1016.10.1016/j.ctrv.2019.07.001671012331302573
- Schorge, J. O., Lea, J. S., Elias, K. J., Rajanbabu, R., Coleman, R. L., Miller, D. S., Ashfaq, R. (2004). p16 as a molecular biomarker of cervical adenocarcinoma. Amer. J. Obstet. Gynecol., 190, 668–673.10.1016/j.ajog.2003.09.03815041997
- Tainio, K., Athanasiou, A., Tikkinen, K. A. O., Aaltonen, R., Cárdenas, J., Hernándes Glazer-Livson, S., Jakobsson, M., Joronen, K., Kiviharju, M., et al. (2018). Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: Systematic review and meta-analysis. Brit. Med. J., 360, k499.10.1136/bmj.k499582601029487049
- Trifonova, R. T., Lieberman. J., van Baarle, D. (2014). Distribution of immune cells in the human cervix and implications for HIV transmission. Amer. J. Reprod. Immunol., 71 (3), 252–64.10.1111/aji.12198394353424410939
- Van Niekerk, D., Guillaud, M., Matisic, J., Benedet, J. L., Freeberg, J. A., Follen, M., MacAulay, C. (2007). p16 and MIB1improve the sensitivity and specificity of the diagnosis of high grade squamous intraepithelial lesions: Methodological issues in a report of 447 biopsies with consensus diagnosis and HPV HCII testing. Gynecol. Oncol., 107, S233–240.10.1016/j.ygyno.2007.07.064
- Vattai, A., Kremer, N., Meister, S., Beyer, S., Keilmann, L., Hester, A., Temelkov, M., Heidegger, H., Schmoeckel, E., Kessler, M., Mahner, S., Jeschke, U., Hertlein, L., Kolben, T. (2021). Role of FoxP3-positive regulatory T cells in regressive and progressive cervical dysplasia. J. Cancer Res. Clin. Oncol., 148 (2), 377–386. doi: 10.1007/s00432-021-03838-6.10.1007/s00432-021-03838-634739585
- Weston, G., Dombrowski, C., Harvey, M. J., Iftner, T., Kyrgiou, M., Founta, C., Adams, E. J. (2020). Use of the Aptima mRNA high-risk human papillomavirus (HR-HPV) assay compared to a DNA HR-HPV assay in the English cervical screening programme: A decision tree model based economic evaluation. BMJ Open, 10 (3), e031303.10.1136/bmjopen-2019-031303706407132152154
- Zheng, Hu., Ding, Ma. (2018). The precision prevention and therapy of HPV-related cervical cancer: New concepts and clinical implications. Cancer Med., 7 (10), 5217–5236.10.1002/cam4.1501
- Yang, H., Ye, S., Goswami, S., Li, T., Wu, J., Cao, C., Ma, J., Lu, B., Pie, X., Chen, Y., Yu, J., Xu, H., Qiu, L., Afridi, S., Xiang, L., Zhang, X. (2020). Highly immunosuppressive HLADRhi regulatory T cells are associated with unfavorable outcomes in cervical squamous cell carcinoma. Int. J. Cancer, 146 (7), 1993–2006.10.1002/ijc.3278231709528